Health inequalities, the financial crisis, and infectious disease in Europe
This report summarises the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers. Presenting key findings from studies on the subject, it makes the case that socio-economic determinants can have a substantial impact on infectious disease control in Europe.
This report addresses key emerging issues related to health inequalities and infectious disease control in the EU with potential links to the economic downturn.
The financial crisis continues to influence many of the key social determinants of health in Europe, both through changes to living conditions and to public spending. Health inequalities are present within the EU/EEA and recent evidence suggests that the financial crisis may have widened inequalities in many EU Member States as well as possibly adversely impacting members of vulnerable groups.
Infectious diseases, like other health issues, can be seen as both an indicator and product of the structure of society. Individuals are rarely subject to one key health determinant but often multiple determinants interact to affect health outcomes such as; wealth and distribution, unemployment, education, and the living environment and urbanisation. The report highlights the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers.
In conjunction with the report, ECDC is hosting a meeting in Stockholm which will discuss to what extent health inequalities are important for infectious disease prevention and control, and share experiences and best practices on how negative effects can be mitigated. It will be attended by experts from most Members States as well as international experts on the subject.
Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings
6 May 2021 - This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in occupational settings in the European Union/European Economic Area (EU/EEA), and provides information on the use of such tests in an occupational safety and health at work context.
Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA
6 May 2021 - This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; current vaccination phases and priority groups, as well as any adjustments made to priority groups during the rollout; vaccination strategies and policies in place; and the use of vaccination certificates and challenges countries face with the rollout and good practices to mitigate these challenges.
Guidance for representative and targeted genomic SARS-CoV-2 monitoring
3 May 2021 - This document offers practical guidance for EU/EEA Member States on implementing genomic SARS-CoV-2 surveillance. It also includes advice on how to estimate the number of sequenced samples needed to achieve various objectives, including the early detection of novel variants.